111 related articles for article (PubMed ID: 22814519)
1. Role of mean platelet volume in acute exacerbation of chronic obstructive pulmonary disease.
Varol E
Pol Arch Med Wewn; 2012; 122(7-8):380-1. PubMed ID: 22814519
[No Abstract] [Full Text] [Related]
2. Mean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary disease.
Ulasli SS; Ozyurek BA; Yilmaz EB; Ulubay G
Pol Arch Med Wewn; 2012; 122(6):284-90. PubMed ID: 22576316
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease.
Karadeniz G; Aktoğu S; Erer OF; Kır SB; Doruk S; Demir M; Sonat K
Biomark Med; 2016 Jul; 10(7):701-10. PubMed ID: 27339097
[TBL] [Abstract][Full Text] [Related]
4. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Wang RT; Li JY; Cao ZG; Li Y
Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
[TBL] [Abstract][Full Text] [Related]
5. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.
Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E
Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328
[TBL] [Abstract][Full Text] [Related]
6. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease.
Biljak VR; Pancirov D; Cepelak I; Popović-Grle S; Stjepanović G; Grubišić TŽ
Platelets; 2011; 22(6):466-70. PubMed ID: 21506665
[TBL] [Abstract][Full Text] [Related]
7. The role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease.
Kurtipek E; Bekci TT; Kesli R; Sami SS; Terzi Y
J Pak Med Assoc; 2015 Dec; 65(12):1283-7. PubMed ID: 26627508
[TBL] [Abstract][Full Text] [Related]
8. [Effect of depsides salts from salvia miltiorrhiza on functions of platelet and vascular endothelial cell of patients with chronic obstructive pulmonary disease in acute exacerbation stage].
He ZB; Jin LY; Chai XP; Zhang DS
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 May; 22(5):279-81. PubMed ID: 20519076
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the neutrophil-lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients.
Taylan M; Demir M; Kaya H; Selimoglu Sen H; Abakay O; Carkanat Aİ; Abakay A; Tanrikulu AC; Sezgi C
Clin Respir J; 2017 May; 11(3):311-317. PubMed ID: 26096858
[TBL] [Abstract][Full Text] [Related]
10. The clinical implication of serum cyclophilin A in patients with chronic obstructive pulmonary disease.
Zhang M; Tang J; Yin J; Wang X; Feng X; Yang X; Shan H; Zhang Q; Zhang J; Li Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():357-363. PubMed ID: 29403273
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein levels in patients with chronic obstructive pulmonary disease: role of infection.
Bircan A; Gokirmak M; Kilic O; Ozturk O; Akkaya A
Med Princ Pract; 2008; 17(3):202-8. PubMed ID: 18408388
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
13. Correlation between decrease of CRP and resolution of airway inflammatory response, improvement of health status, and clinical outcomes during severe acute exacerbation of chronic obstructive pulmonary disease.
Liang Y; Chang C; Zhu H; Shen N; He B; Yao W
Intern Emerg Med; 2015 Sep; 10(6):685-91. PubMed ID: 25822151
[TBL] [Abstract][Full Text] [Related]
14. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations.
Wouters EF; Groenewegen KH; Dentener MA; Vernooy JH
Proc Am Thorac Soc; 2007 Dec; 4(8):626-34. PubMed ID: 18073394
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio for hospital mortality in patients with AECOPD.
Yao C; Liu X; Tang Z
Int J Chron Obstruct Pulmon Dis; 2017; 12():2285-2290. PubMed ID: 28814856
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?
Sin DD; Man SF
Thorax; 2006 Jan; 61(1):1-3. PubMed ID: 16396949
[TBL] [Abstract][Full Text] [Related]
17. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
[TBL] [Abstract][Full Text] [Related]
18. C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach.
Dahl M; Vestbo J; Zacho J; Lange P; Tybjærg-Hansen A; Nordestgaard BG
Thorax; 2011 Mar; 66(3):197-204. PubMed ID: 21059738
[TBL] [Abstract][Full Text] [Related]
19. [More research is needed to understand the airway inflammation in chronic obstructive pulmonary disease].
He P
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2089-91. PubMed ID: 19080465
[No Abstract] [Full Text] [Related]
20. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
Lung; 2008; 186(6):403-9. PubMed ID: 18807087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
